DOSSIER · UPDATED 18 JUN 2026

Sharp Therapeutics

Imagine a world where genetic diseases are treated with orally-available small molecule drugs. That's the future Sharp Edge Labs is building. Sharp Edge is a preclinical-stage life sciences company developing drugs for genetic diseases.…

sharptx.com ↗Claim this profile

Founded: 2010
Headcount: 6
Open roles: 0
Last raised: Post Ipo Debt · $2M

SECTION I · THE BRIEF

Inside Sharp Therapeutics

Brief #59848Updated 18 JUN 2026PITTSBURGHMEDICAL ORGANIZATIONSPOST IPO DEBT

Employbl Dossier

Sharp Therapeutics

Founded: 2010
Headcount: 6
Open roles: 0
Last raised: Post Ipo Debt · $2M

Section II · Premium ProfileMembers only

01Engineering interview process at Sharp TherapeuticsLocked
02Tech stack & infrastructure choicesLocked
03Culture & day-to-day work styleLocked
04Why join now vs. 6 months from nowLocked
05Hiring focus & open headcount by teamLocked
06Comp philosophy and band contextLocked

Open Sharp Therapeutics brief Sign in

7-day free trial · $25/mo · cancel anytime

LEADERSHIP

Founders & key people

Alan Waggoner

Marcel P. Bruchez

OPEN ROLES

Hiring at Sharp Therapeutics

No open roles listed right now. Check back soon or search all jobs →

FUNDING

Capital raised

Total Amount Raised: $8,647,759